fls.txt
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) provides a historical and prospective narrative on the Company’s financial condition and results of operations.


item1.txt
For additional information and updates to estimated liabilities as of September 30, 2019, see Part I, Item 1, Financial Statements, Note 3 (Commitments, Contingencies and Guarantees) of the Notes to Unaudited Consolidated Financial Statements included under Item 1 of this quarterly report, which is incorporated herein by reference.


item2.txt
Under the Framework, we targeted generating $26 billion to $30 billion of cash through 2019, returning more than $12.5 billion to shareholders and investing $10 billion to extend our leadership positions and deliver growth.
From 2020 to 2023, the company plans to invest $10 billion to $12 billion for growth and to return $8 billion to $10 billion to shareholders.
© 2019 Corning Incorporated.
Life Sciences net sales increased by $25 million, as volume grew faster than the underlying market.
Life Sciences net sales increased by $51 million, as volume grew faster than the underlying market.
Lower segment net income of $33 million, $41 million and $24 million for the Display Technologies, Optical Communications and Specialty Materials segments, respectively.
The decreases in net income outlined above were slightly offset by higher net income for the Environmental Technologies and Life Sciences segments of $19 million and $11 million, respectively.
Diluted earnings per share decreased by $0.29 per share when compared to the third quarter of 2018, driven by the decrease in net income described above, offset by the repurchase of 34.7 million shares of common stock over the last twelve months.
© 2019 Corning Incorporated.
Diluted earnings per share increased by $0.21 per share when compared to the same period in 2018, driven by the increase in net income described above, coupled with the repurchase of 34.7 million shares of common stock over the last twelve months.
© 2019 Corning Incorporated.
© 2019 Corning Incorporated.
Life Sciences net sales increased by $25 million, as volume grew faster than the underlying market.
Movements in foreign exchange rates did not materially impact Corning’s consolidated net sales in the three months ended September 30, 2019, when compared to the prior year.
Life Sciences net sales increased by $51 million, as volume grew faster than the underlying market.
Movements in foreign exchange rates did not materially impact Corning’s consolidated net sales in the nine months ended September 30, 2019, when compared to the prior year.
In the three and nine months ended September 30, 2019, gross margin decreased by $215 million, or 17%, and $78 million, or 2%, respectively.
When compared to the first nine months of 2018, selling, general and administrative expenses decreased by $168 million, or 12%, in the nine months ended September 30, 2019.
Selling, general and administrative expenses declined as a percentage of sales by 2% for the three and nine months ended September 30, 2019.
© 2019 Corning Incorporated.
For the three and nine months ended September 30, 2019, research, development and engineering expenses increased by $11 million, or 5%, and $25 million, or 3%, respectively, when compared to the same periods last year, driven by higher costs associated with new product launches and our emerging businesses.
In the third quarter ending September 30, 2019, equity in earnings of affiliated companies declined by $9 million primarily driven by lower sales volumes for some of our affiliates.
Equity in earnings of affiliated companies for the nine months ended September 30, 2019 decreased by $21 million, primarily driven by the absence of a gain recorded in the first quarter of 2018 resulting from a legal settlement.
© 2019 Corning Incorporated.
© 2019 Corning Incorporated.
For the three months ended September 30, 2019 comprehensive income decreased by $444 million when compared to the same period in 2018, due to lower net income of $288 million and $110 million of negative impacts from the change in foreign currency translation losses, driven primarily by the Korean won.


item3.txt



item4.txt
Corning’s disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by Corning in the reports that it files or submits under the Exchange Act is accumulated and communicated to Corning’s management, including Corning’s principal executive and principal financial officers, or other persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.


part2.txt
See our 2018 Form 10-K, Part I, Item 3.


